Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | CES2 | O00748 | 3/20 | 0.71 |
| ▸ | CES1 | P23141 | 3/20 | 0.71 |
| ▸ | KEAP1 | Q14145 | 1/20 | 0.63 |
| ▸ | KDM4E | B2RXH2 | 3/20 | 0.49 |
| ▸ | ALDH1A1 | P00352 | 2/20 | 0.49 |
| ▸ | TTR | P02766 | 2/20 | 0.49 |
| ▸ | ALB | P02768 | 2/20 | 0.49 |
| ▸ | MEN1 | O00255 | 1/20 | 0.49 |
| ▸ | USP2 | O75604 | 1/20 | 0.49 |
| ▸ | DHFR | P00374 | 1/20 | 0.49 |
| ▸ | CA1 | P00915 | 1/20 | 0.49 |
| ▸ | CA2 | P00918 | 1/20 | 0.49 |
| ▸ | LMNA | P02545 | 1/20 | 0.49 |
| ▸ | HMGB1 | P09429 | 1/20 | 0.49 |
| ▸ | HPGD | P15428 | 1/20 | 0.49 |
| ▸ | CXCL12 | P48061 | 1/20 | 0.49 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.49 |
| ▸ | HIF1A | Q16665 | 1/20 | 0.49 |
| ▸ | SLC22A6 | Q4U2R8 | 1/20 | 0.49 |
| ▸ | ACMSD | Q8TDX5 | 1/20 | 0.49 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL29798953 | 0.98 | CES2 (0.68) | CES2CES1KEAP1KDM4EALDH1A1 | |
| SCHEMBL28742361 | 0.98 | CES2 (0.68) | CES2CES1KEAP1KDM4EALDH1A1 | |
| Formic Acid SCHEMBL28119411 | 0.90 | CES2 (0.59) | CES2CES1KEAP1KDM4EALDH1A1 | |
| Formic Acid SCHEMBL28119412 | 0.85 | CES2 (0.53) | CES2CES1KEAP1KDM4EALDH1A1 | |
| SCHEMBL27740945 | 0.84 | KEAP1 (0.56) | CES2CES1KEAP1KDM4EALDH1A1 | |
| SCHEMBL27673772 | 0.83 | CES2 (0.74) | CES2CES1KEAP1ALDH1A1MEN1 | |
| SCHEMBL3180092 | 0.83 | CES2 (1.00) | CES2CES1KEAP1CA3CA6 | |
| SCHEMBL336978 | 0.83 | KEAP1 (0.65) | CES2CES1KEAP1KDM4EALDH1A1 | |
| SCHEMBL30520290 | 0.83 | KEAP1 (0.65) | CES2CES1KEAP1KDM4EALDH1A1 | |
| SCHEMBL3062072 | 0.83 | BCL2L1 (0.55) | CES2CES1KEAP1KDM4EALDH1A1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 990 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-4661890-A1 | PTP1B/TC-PTP DUAL INHIBITORS AND PROTEIN DEGRADERS | Purdue Research Foundation (US) | 2025-12-17 | — | — | EP | claimed |
| US-20250347195-A1 | OPTIMIZING CO2 GEOSEQUESTRATION WITH RESPONSIVE TRACERS | ARAMCO SERVICES COMPANY (US) | 2025-11-13 | — | — | US | claimed |
| CN-119414657-A | Fluorine-containing titanium oxide nanoparticle photoresist material, preparation method thereof and application thereof in photoetching technology | 山东大学 | 2025-02-11 | — | — | CN | claimed |
| WO-2024167565-A1 | PTP1B/TC-PTP DUAL INHIBITORS AND PROTEIN DEGRADERS | PURDUE RESEARCH FOUNDATION (US) | 2024-08-15 | — | — | WO | claimed |
| US-11994020-B2 | Mapping inter-well porosity using tracers with different transport properties | SAUDI ARABIAN OIL COMPANY (SA) | 2024-05-28 | — | — | US | claimed |
| CN-114539029-B | Synthesis method of 5-fluoro salicylic acid | 浙江中欣氟材股份有限公司 | 2024-04-09 | — | — | CN | claimed |
| US-20240093598-A1 | MAPPING INTER-WELL POROSITY USING TRACERS WITH DIFFERENT TRANSPORT PROPERTIES | ARAMCO SERVICES COMPANY (US) | 2024-03-21 | — | — | US | claimed |
| CN-116444454-B | N-hydroxy amidine derivative, preparation method and application thereof, and tumor immunotherapy medicament | 中国医学科学院医药生物技术研究所 | 2023-09-12 | — | — | CN | claimed |
| CN-113880868-B | Binuclear rare earth complex crystalline material and preparation method and application thereof | 江西师范大学 | 2023-09-08 | — | — | CN | claimed |
| CN-116444454-A | N-hydroxy amidine derivative, preparation method and application thereof, and tumor immunotherapy medicament | 中国医学科学院医药生物技术研究所 | 2023-07-18 | — | — | CN | claimed |
| US-20050090690-A1 | Process for preparing tetra-amide compounds | XEROX CORPORATION | 2005-04-28 | — | — | US | claimed |
| US-20040094297-A1 | Method for determining the extent of recovery of materials injected into oil wells or subsurface formations during oil and gas exploration and production | CORE LABORATORIES LP | 2004-05-20 | — | — | US | claimed |
| US-6659175-B2 | Mixing water, buffers, oxidizers, gels, gelation inhibitors, stabilizer and curing agents with tracers, then pumping the mixtures into bores, withdrawing fluids and measuring concentration of labels; well completion efficiency | CORE LABORATORIES, INC. | 2003-12-09 | — | — | US | claimed |
| US-20030006036-A1 | Mixing water, buffers, oxidizers, gels, gelation inhibitors, stabilizer and curing agents with tracers, then pumping the mixtures into bores, withdrawing fluids and measuring concentration of labels; well completion efficiency | CORE LABORATORIES GLOBAL N.V. (NL) | 2003-01-09 | — | — | US | claimed |
| WO-2002095189-A1 | METHOD OF DETERMINING THE EXTENT OF RECOVERY OF MATERIALS INJECTED INTO OIL WELLS | CORE LABORATORIES L.P. (US) | 2002-11-28 | — | — | WO | claimed |
| EP-0539274-B1 | Method for the synthesis of aldehydes and of their derivatives | RHONE POULENC CHIMIE (FR) | 1996-04-10 | — | — | EP | claimed |
| US-5354495-A | Homo- or copolymerizable through ethylenic unsaturation | NIPPON PAINT CO., LTD. (JP) | 1994-10-11 | — | — | US | claimed |
| EP-0177122-B1 | ACRYLAMIDE DERIVATIVES | Nippon Paint Co., Ltd. (JP) | 1992-04-01 | — | — | EP | claimed |
| US-H992-H | Using copper catalyst in quinoline or n-methyl-2-pyrrolidone | OCCIDENTAL CHEMICAL CORPORATION (US) | 1991-11-05 | — | — | US | claimed |
| US-4935413-A | ELASTICITY, ADHESION AND DISPERSIBILITY | NIPPON PAINT CO., LTD. (JP) | 1990-06-19 | — | — | US | claimed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20050090690-A1 | Process for preparing tetra-amide compounds | TAF9, TAF5, TAF1 | CES2 2351/4885CES1 3786/4885KEAP1 2845/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.